PolyPid Ltd at Barclays Global Healthcare Conference Transcript
Good morning, everyone. Welcome to Day 2 of Barclays Global Healthcare Conference. My name is Balaji Prasad. I lead the specialty pharmaceuticals coverage for Barclays. And to kick start our spec pharma track for the day, we have with us a very interesting company, PolyPid, Phase III biopharma company with an interesting lipid polymer matrix for localized delivery. So from the management side, we have with us Dikla Czaczkes, EVP and CFO and also CEO designate. So congratulations, Dikla.
Thank you.
And we have Ori Warshavsky, Chief Operating Officer. And in the audience, we also have Jacob Harel, the Chairman of PolyPid, so welcome, everyone.
So Dikla, why don't we start with a few opening comments from your side. And we also hit a nice milestone recently. So a few opening comments from your side, we can have a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
